Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Long non-coding RNA and applications of long non-coding RNA in diagnosis/treatment of non-small cell lung cancer

A non-small cell lung cancer, non-coding technology, used in DNA/RNA fragments, gene therapy, recombinant DNA technology, etc., can solve the problems of low survival rate, poor chemotherapy regimen for lung cancer, and lost opportunities for surgery.

Active Publication Date: 2016-12-21
克孜勒苏柯尔克孜自治州人民医院
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Many lung cancer patients have metastasized at the time of diagnosis, and often lose the chance of surgery, and the effect of chemotherapy for lung cancer is not good, and the five-year survival rate is less than 5%. It is urgent to find new and effective methods for the treatment of lung cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Long non-coding RNA and applications of long non-coding RNA in diagnosis/treatment of non-small cell lung cancer
  • Long non-coding RNA and applications of long non-coding RNA in diagnosis/treatment of non-small cell lung cancer
  • Long non-coding RNA and applications of long non-coding RNA in diagnosis/treatment of non-small cell lung cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Example 1 Basic verification test of LINC00111 expression level in non-small cell lung cancer

[0035] (1): LINC00111 expression in normal lung tissue and lung cancer tissue

[0036] 1. Chip preparation and analysis: Normal lung tissue and lung cancer tissue samples were prepared according to the requirements of Boao Biological Co., Ltd., and submitted to Boao Biological Co., Ltd. for chip preparation, and the human long-chain non-coding RNA chip V1.0 version completed the chip analysis.

[0037] 2. Microarray analysis: The expression level of LINC00111 in lung cancer was up-regulated by 29.08 times compared with normal lung tissue, suggesting that LINC00111 may function as an oncogene in lung cancer.

[0038] (2): qRT-PCR analysis of the expression of LINC00111 in normal lung epithelial cell line 16HBE and non-small cell lung cancer cell line A549

[0039] 1. Methods: Trizol reagent was used to extract total cellular RNA, and qRT-PCR was performed using SYBR Green PCR M...

Embodiment 2

[0042] Example 2 The therapeutic effect of inhibiting the expression of LINC00111 on non-small cell lung cancer

[0043] 1. Detection of cell apoptosis by flow cytometry:

[0044] The nucleotide sequence of the siRNA of LINC00111 is shown in SEQ ID NO: 4, SEQ ID NO: 5 or SEQ ID NO: 6:

[0045] SEQ ID NO: 4 CAGTGGCTCCAGGTGTAACCCATTT

[0046] SEQ ID NO: 5 GGGATGTTCTGGTGAAGGATCTGAA

[0047] SEQ ID NO: 6 CAACATCAGGAGATCTGACTTCATA

[0048] The sequence fragments that interfere with the GAPDH gene were used as a control, and inserted into a lentiviral vector (the above vectors and fragments were synthesized by Invitrogen). The packaged lentiviral vector was used to infect the non-small cell lung cancer cell line A549 to down-regulate the expression of LINC00111. After 48 hours, the stably transfected cell line was screened with G418 and named A549 / si-LINC00111 (the control was A549 / si- NC). The si-LINC00111 lentiviral interference vector was constructed to infect the A549 cell ...

Embodiment 3

[0054] Example 3 Experiments related to cell drug resistance

[0055] 1. MTT test cell IC50: Construct LINC00111 lentiviral interference vector to transfect A549 cell line (A549 / si-LINC00111), and empty vector to transfect A549 cell line (A549 / si-NC) as the control group. These cell lines were seeded on 96-well plates at 2500 cells / well. Each group was treated with cisplatin or docetaxel, and the cell viability was detected by MTT staining 3 days after administration, and then the IC50 of each drug was calculated.

[0056] 2. Results determination: if figure 2 , 3 shown.

[0057] 3. Analysis of the results: In the A549 cell line, the IC50 of the si-LINC00111 experimental group treated with DDP: 11.01ug / ml, the IC50 (NC) of the control group: 23.26ug / ml; the A549 / si-LINC00111 experimental group treated with DTX IC50: 13.42ug / ml, IC50(NC) of the control group: 25.69ug / ml. This phenomenon was observed, suggesting that reducing the expression of LINC00111 can promote the apo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of genetic engineering, and particularly relates to applications of LINC00111 in preparation of drugs for predicting the prognosis and the target point of non-small cell lung cancer, and treatment. According to the present invention, the expression of LINC00111 in NSCLC is up-regulated, such that the influence on the invasion, the migration and the like of non-small cell lung cancer cells can be produced by changing the expression of LINC00111, and the non-small cell lung cancer cell proliferation can be inhibited and the apoptosis can be induced by knocking down the expression of LINC00111.

Description

technical field [0001] The invention belongs to the field of genetic engineering, in particular to a long non-coding RNA and its application in diagnosis / treatment of non-small cell lung cancer. Background technique [0002] Genomic studies have shown that there are about 20,000 protein-coding genes in the human genome, accounting for about 2% of the total number of genes, and most of the remaining genes are transcribed into non-coding RNA (non-coding RNA, ncRNA). According to their length, ncRNAs can be divided into transcription initiation RNAs, Piwi protein-interacting RNAs, microRNAs, small nucleolar RNAs, and long non-coding RNAs (longnon-coding RNAs, lncRNAs). LncRNA is a class of RNA molecules whose transcripts are more than 200 nucleotides in length and do not encode proteins themselves. LncRNA was originally considered as a by-product of RNA polymerase II transcription, which is the "noise" of genome transcription and has no biological function. However, recent st...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/113C12Q1/68A61K48/00A61K31/7088A61P35/00
CPCA61K31/7088C12N15/113C12N2310/10C12Q1/6886C12Q2600/118C12Q2600/136C12Q2600/158C12Q2600/178C12N2320/30
Inventor 曲晨谭晓姚诚曹喆胡文志李云涛宋宗纬
Owner 克孜勒苏柯尔克孜自治州人民医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com